Nicole Bechmann

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Tumor Necrosis is Associated with an Increased Metastatic and Cardiovascular Risk in Paragangliomas: A Single-Center Series and Meta-Analysis Comparing Necrosis and Cystic Degeneration in Paragangliomas.

Tumor Necrosis is Associated with an Increased Metastatic and Cardiovascular Risk in Paragangliomas: A Single-Center Series and Meta-Analysis Comparing Necrosis and Cystic Degeneration in Paragangliomas.

Journal: Endocrine pathology

Published: January 21, 2026

Primary Aldosteronism: Small Molecule Antagonists of Mutant KCNJ5 Potassium Channels.

Primary Aldosteronism: Small Molecule Antagonists of Mutant KCNJ5 Potassium Channels.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: November 20, 2025

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Journal: Scientific reports

Published: November 12, 2025

Adrenal-adipose tissue crosstalk in health and disease.

Adrenal-adipose tissue crosstalk in health and disease.

Journal: European journal of endocrinology

Published: October 08, 2025

Patient-derived organoids reveal hypoxia-driven plasticity and therapeutic vulnerabilities in pheochromocytomas and paragangliomas.

Patient-derived organoids reveal hypoxia-driven plasticity and therapeutic vulnerabilities in pheochromocytomas and paragangliomas.

Journal: bioRxiv : the preprint server for biology

Published: September 02, 2025

Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells.

Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells.

Journal: Endocrine-related cancer

Published: July 03, 2025

Clinical and biochemical characteristics of patients with somatic HRAS-mutant pheochromocytoma and paraganglioma.

Clinical and biochemical characteristics of patients with somatic HRAS-mutant pheochromocytoma and paraganglioma.

Journal: European journal of endocrinology

Published: May 15, 2025

Glucocorticoid and mineralocorticoid production in hormonally silent adrenocortical tumor tissue in dogs.

Glucocorticoid and mineralocorticoid production in hormonally silent adrenocortical tumor tissue in dogs.

Journal: Journal of veterinary internal medicine

Published: April 30, 2025

Commentary on "Plasmacytoid Dendritic Cell Content Is Associated With Plasma Aldosterone Concentration in Patients With Primary Aldosteronism".

Commentary on "Plasmacytoid Dendritic Cell Content Is Associated With Plasma Aldosterone Concentration in Patients With Primary Aldosteronism".

Journal: American journal of hypertension

Published: March 12, 2025

Human adrenocortical organoids for tissue regeneration and disease modeling.

Human adrenocortical organoids for tissue regeneration and disease modeling.

Journal: Stem cell reports

Published: February 15, 2025

Continuous flow-through steady state system for in vitro characterization of CYP11B2 inhibitors-Impact on enzyme kinetics of steroidogenesis.

Continuous flow-through steady state system for in vitro characterization of CYP11B2 inhibitors-Impact on enzyme kinetics of steroidogenesis.

Journal: The Journal of steroid biochemistry and molecular biology

Published: November 11, 2024

Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma.

Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 29, 2024

Showing 1-12 of 99

Last Updated: 09/26/2026